I. Dayananda

发表

Pharmacy worker practices related to use of misoprostol for abortion in one Mexican state.

D. Billings, K. Clark, D. Walker, 2009, Contraception.

Same-Day Compared With Overnight Cervical Preparation Before Dilation and Evacuation Between 16 and 19 6/7 Weeks of Gestation

M. Dragoman, G. Stoffels, I. Dayananda, 2022, Obstetrics and gynecology.

Continuation rates of two different-sized copper intrauterine devices among nulliparous women: Interim 12-month results of a single-blind, randomised, multicentre trial

B. Kaneshiro, A. Burke, D. Archer, 2022, EClinicalMedicine.

Can women accurately assess the outcome of medical abortion based on symptoms alone?

G. Fitzmaurice, J. Fortin, A. Goldberg, 2012, Contraception.

Medical Abortion Follow-up With Serum Human Chorionic Gonadotropin Compared With Ultrasonography: A Randomized Controlled Trial

R. Maurer, J. Fortin, A. Goldberg, 2013, Obstetrics and gynecology.

An Exploratory Study of Transgender New Yorkers' Use of Sexual Health Services and Interest in Receiving Services at Planned Parenthood of New York City

G. Dean, I. Dayananda, L. Porsch, 2016, Transgender health.

[Legislation, knowledge and attitudes of health professionals in Mexico regarding abortion].

D. Walker, Erika E. Atienzo, I. Dayananda, 2013, Salud Colectiva.

Abortion practice in Mexico: a survey of health care providers.

S. Haider, D. Walker, Erika E. Atienzo, 2012, Contraception.

Comparing Receipt of Cervical Cancer Screening and Completion of Human Papillomavirus Vaccination Using a New Construct of Sexual Orientation: A Serial Cross-Sectional Study.

Hongbin Zhang, G. Dean, I. Dayananda, 2019, LGBT health.

Adjuvant misoprostol or mifepristone for cervical preparation with osmotic dilators before dilation and evacuation.

I. Dayananda, B. Lunde, Lauren M. Porsch, 2024, Contraception.